← back to database

Pfizer Ventures

HQ · New York

Pfizer Ventures is Pfizer’s strategic corporate venture arm. It invests globally from Seed through IPO, with a strong emphasis on early-stage biopharmaceutical companies developing transformative therapeutics and platform technologies in Pfizer’s core disease areas. Typical initial investments are $5 million–$20 million, and the team can lead or join syndicates.

Primary stage
SeedSeries ASeries B
Lead / follow
Can Lead
Initial check size
$3M - $10M$10M - $30M
Specialization
Life Sciences
Generalist / Specialist

Specialist

Latest fund size

$600 million additional commitment announced in 2018

Latest fund vintage

2018


Investing team
  • Michael C. DiemSenior Managing Partner
  • Rana Al-HallaqPartner
  • Irena MelnikovaPartner
  • Christopher O'DonnellPartner
  • Marie-Claire PeakmanPartner
  • Anthony BarryPartner

Pfizer Ventures — early-stage investor profile | findfunding.vc